XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel
· Delayed Price · Currency is ILS · Price in ILA 3.000
+1.200 (66.67%)
Apr 29, 2026, 4:31 PM IDT
XTL Biopharmaceuticals Employees
XTL Biopharmaceuticals had 10 employees as of December 31, 2024. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
326.15K ILS
Profits / Employee
-2.13M ILS
Market Cap
17.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10 | 3 | 42.86% |
| Dec 31, 2016 | 7 | 1 | 16.67% |
| Dec 31, 2015 | 6 | 1 | 20.00% |
| Dec 31, 2014 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Purple Biotech | 10 |
| Can-Fite BioPharma | 5 |
| BioLight Life Sciences | 4 |
| Evogene | 52 |
| BioLineRx | 24 |
| Matricelf | 15 |
| Geffen Residence & Renewal | 6 |
| Bonus BioGroup | 37 |
XTL Biopharmaceuticals News
- 5 weeks ago - XTL Biopharmaceuticals (XTLB) Adjusts ADS to Ordinary Share Ratio - GuruFocus
- 5 weeks ago - XTL Biopharmaceuticals Announces ADS Ratio Change - GlobeNewsWire
- 2 months ago - XTL Biopharmaceuticals (XTLB) Faces Nasdaq Delisting Threat - GuruFocus
- 2 months ago - XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing - GlobeNewsWire
- 3 months ago - XTL Biopharmaceuticals Aims to Acquire Stake in NeuroNOS from Beyond Air (XAIR) - GuruFocus
- 3 months ago - XTL Update on Recent Developments - GlobeNewsWire
- 3 months ago - XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - GlobeNewsWire
- 3 months ago - XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership - GlobeNewsWire